Aparna Raychaudhuri Selected Research

gepotidacin

12/2022	Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants.
1/2022	Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague.
1/2020	Pharmacokinetics of Gepotidacin in Renal Impairment.
12/2018	Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae.
1/2018	Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aparna Raychaudhuri Research Topics

Disease

6	Dry Eye Syndromes (Dry Eye Syndrome) 07/2019 - 12/2015
2	Urinary Tract Infections (Urinary Tract Infection) 12/2022 - 01/2020
2	Pain (Aches) 07/2019 - 01/2017
2	Gonorrhea 12/2018 - 01/2018
2	Inflammation (Inflammations) 01/2017 - 12/2015
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2013 - 07/2013
2	Multiple Sclerosis 09/2008 - 09/2006
1	Plague (Bubonic Plague) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Dysgeusia (Parageusia) 07/2019
1	Pruritus (Itching) 01/2017
1	Photophobia (Light Sensitivity) 01/2017
1	Foreign Bodies (Foreign Body) 01/2017
1	Schizophrenia (Dementia Praecox) 12/2014
1	Infections 09/2008
1	Pathologic Complete Response 09/2008
1	Relapsing-Remitting Multiple Sclerosis 09/2008
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2007
1	Breast Neoplasms (Breast Cancer) 09/2006

Drug/Important Bio-Agent (IBA)

6	lifitegrastIBA 07/2019 - 12/2015
5	gepotidacinIBA 12/2022 - 01/2018
3	Lisdexamfetamine Dimesylate FDA Link 12/2014 - 07/2013
2	Nitrofurantoin (Macrodantin)FDA LinkGeneric 12/2022 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2020
2	InterleukinsIBA 09/2008 - 09/2006
2	Interleukin-12 (IL 12)IBA 09/2008 - 09/2006
2	Monoclonal AntibodiesIBA 09/2008 - 09/2006
1	DNA Topoisomerase IV (Topoisomerase IV)IBA 01/2022
1	Bacterial DNAIBA 01/2022
1	Topoisomerase InhibitorsIBA 01/2018
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 01/2017
1	IntegrinsIBA 12/2015
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 12/2014
1	ProdrugsIBA 12/2014
1	Antipsychotic Agents (Antipsychotics)IBA 12/2014
1	GadoliniumIBA 09/2008
1	Ustekinumab (CNTO 1275)FDA Link 09/2008
1	Infliximab (Remicade)FDA Link 09/2007
1	Methotrexate (Mexate)FDA LinkGeneric 09/2007

Therapy/Procedure

1	Renal Dialysis (Hemodialysis) 01/2020
1	Therapeutics 12/2018
1	Drug Therapy (Chemotherapy) 12/2014
1	Subcutaneous Injections 09/2008